SAI LIFE SCIENCES LIMITED (SAILIFE) Share Price Hits 52-Week High
- July 29, 2026
- Posted by: Harsh Piplani
- Category: News
SAI LIFE SCIENCES LIMITED Share Price reached a fresh 52-week high of Rs 1,311.05, with a current price of Rs 1,307.35, marking a 0.54% increase today. The market capitalisation stands at Rs 27,346.77 crore.
SAI LIFE SCIENCES LIMITED Share Price has achieved a fresh 52-week high, reaching Rs 1,311.05. The stock is currently trading at Rs 1,307.35, reflecting a 0.54% increase from the previous close of Rs 1,300.3. The company’s market capitalisation is Rs 27,346.77 crore, highlighting its significant presence in the healthcare sector. This milestone in the share price underscores the stock’s recent momentum, drawing attention from investors and analysts alike. While the data confirms the price event, it does not establish a specific catalyst for this upward movement.
SAI LIFE SCIENCES LIMITED Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,307.35 |
| Previous Close | Rs 1,300.3 |
| Today's Change | +Rs 7.05 (+0.54%) |
| Day Open | Rs 1,309.05 |
| Fresh 52-Week High | Rs 1,311.05 |
| Day Low | Rs 1,291.5 |
| Current Volume | 3,592 |
| Turnover | Rs 0.47 crore |
| Market Capitalisation | Rs 27,346.77 crore |
Today’s trading session saw SAI LIFE SCIENCES LIMITED opening at Rs 1,309.05, reaching a high of Rs 1,311.05, and dipping to a low of Rs 1,291.5. The turnover for the day was Rs 0.47 crore, with a volume of 3,592 shares traded. The stock’s breakout to a new 52-week high indicates positive investor sentiment, although the exact catalyst remains unidentified. This price action sets the stage for further analysis of the company’s fundamentals and sector positioning.
SAI LIFE SCIENCES LIMITED (SAILIFE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 27,346.77 crore |
| P/E Ratio | 29.31x |
| P/B Ratio | 0.43x |
| ROE | -2.89% |
| ROCE | -0.26% |
SAI LIFE SCIENCES LIMITED was valued at a P/E ratio of 29.31x, a P/B ratio of 0.43x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 29.31x |
| Benchmark Median P/E | 21.06x |
| Benchmark Average P/E | 68.59x |
| Benchmark P/E Range | 0x to 3,439.3x |
| Company P/B Ratio | 0.43x |
| Benchmark Median P/B | 1.88x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.91% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.2% |
| Company Market Capitalisation | Rs 27,346.77 crore |
| Benchmark Median Market Cap | Rs 140.64 crore |
SAI LIFE SCIENCES LIMITED (SAILIFE) is classified under sector: Healthcare. The numerical benchmark uses 198 same sector companies from the supplied master-data set.
SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 29.31x, which is above the benchmark median of 21.06x, a difference of +39.17%. The benchmark contains 198 companies with P/E data, ranging from 0x to 3,439.3x. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROE of -2.89%, which is below the benchmark median of 10.91%, a difference of -126.49%. SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROCE of -0.26%, which is below the benchmark median of 13.2%, a difference of -101.97%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,921.65 | 29.31 | 0.43 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,815.27 | 39.89 | 8.12 | 28.21 | 26.35 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,476.69 | 169.37 | 3.13 | 13.9 | 12.97 |
| Beta Drugs Ltd. | BETA | 2,472.93 | 56.38 | 8.92 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,444.35 | 34.87 | 7.06 | -2.6 | 16.92 |
SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 29.31x compared with the displayed peer median of 39.89x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. SAI LIFE SCIENCES LIMITED (SAILIFE) has a market capitalisation of Rs 27,346.77 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching SAI LIFE SCIENCES LIMITED
- SAI LIFE SCIENCES LIMITED Share Price reached a fresh 52-week high of Rs 1,311.05.
- The company’s P/E ratio is above the sector median, indicating moderate valuation.
- Market capitalisation of Rs 27,346.77 crore highlights its industry prominence.
- Negative ROE and ROCE suggest challenges in profitability and efficiency.
- Potential undervaluation indicated by a low P/B ratio compared to the sector.
About SAI LIFE SCIENCES LIMITED
SAI LIFE SCIENCES LIMITED operates in the healthcare sector, focusing on providing a range of pharmaceutical and healthcare solutions. The company is known for its innovative approaches in drug development and manufacturing, catering to a diverse clientele. With a strong emphasis on research and development, SAI LIFE SCIENCES LIMITED aims to deliver high-quality healthcare products and services. Its significant market capitalisation reflects its established position in the industry, making it a key player in the healthcare sector.
Track SAI LIFE SCIENCES LIMITED Share Price on Univest
Use SAI LIFE SCIENCES LIMITED (SAILIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors can track the live share price of SAI LIFE SCIENCES LIMITED on Univest, along with technical indicators, fundamental ratios, shareholding patterns, 52-week levels, and market insights. Univest provides comprehensive data to help investors make informed decisions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of SAI LIFE SCIENCES LIMITED?
Ans. The current share price of SAI LIFE SCIENCES LIMITED is Rs 1,307.35, reflecting a 0.54% increase from the previous close of Rs 1,300.3. The stock moved 0.54% during the session.
What is the market capitalisation of SAI LIFE SCIENCES LIMITED?
Ans. The market capitalisation of SAI LIFE SCIENCES LIMITED is Rs 27,346.77 crore, indicating its significant presence in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 29.31x.
What is the P/E ratio of SAI LIFE SCIENCES LIMITED?
Ans. SAI LIFE SCIENCES LIMITED has a P/E ratio of 29.31, which is above the sector median of 21.06 but below the sector average of 68.59. The company trades at a P/E ratio of 29.31x.
How does SAI LIFE SCIENCES LIMITED's P/B ratio compare to the sector?
Ans. The P/B ratio of SAI LIFE SCIENCES LIMITED is 0.43, significantly lower than the sector median of 1.88, suggesting potential undervaluation. The company trades at a P/E ratio of 29.31x.
What are the ROE and ROCE of SAI LIFE SCIENCES LIMITED?
Ans. SAI LIFE SCIENCES LIMITED has a negative ROE of -2.89% and a negative ROCE of -0.26%, indicating challenges in profitability and capital efficiency. ROE stands at -2.89%. ROCE stands at -0.26%.
How does SAI LIFE SCIENCES LIMITED compare to its peers?
Ans. SAI LIFE SCIENCES LIMITED has a larger market capitalisation than its peers but shows negative ROE and ROCE, contrasting with the positive metrics of some peers. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Sai Parenteral's Ltd.
What is the 52-week high of SAI LIFE SCIENCES LIMITED?
Ans. The 52-week high of SAI LIFE SCIENCES LIMITED is Rs 1,311.05, achieved recently, indicating strong price momentum. The stock moved 0.54% during the session. The intraday range extended from Rs 1,291.5 to Rs 1,311.05.
What sector does SAI LIFE SCIENCES LIMITED operate in?
Ans. SAI LIFE SCIENCES LIMITED operates in the healthcare sector, focusing on pharmaceutical and healthcare solutions. The stock belongs to the Healthcare sector. 198 comparable companies were included in the benchmark.
What is the significance of SAI LIFE SCIENCES LIMITED's market cap?
Ans. The market cap of Rs 27,346.77 crore highlights SAI LIFE SCIENCES LIMITED's prominence and significant presence in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 29.31x.
Where can I track SAI LIFE SCIENCES LIMITED's share price?
Ans. You can track SAI LIFE SCIENCES LIMITED's share price on Univest, which provides live updates, technical indicators, and market insights. The stock moved 0.54% during the session. The intraday range extended from Rs 1,291.5 to Rs 1,311.05.
